Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report | The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report from PwC.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players…

The number of insurers offering plans on the Affordable Care Act's marketplaces declined between 2025 and 2026, with more payers…

The first quarter of 2026 brought plenty of opportunity for HCA Healthcare to stock up on outpatient facilities, with management…

Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement…

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the…

Health insurance executives convene this week in Las Vegas at a time when the industry is facing significant pressure around…